Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.
2.

Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.

Gawade PL, Berlin JA, Henry DH, Tomita D, Brooks BD, Franklin J, Bradbury BD, Critchlow CW.

Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1357-1366. doi: 10.1002/pds.4293. Epub 2017 Aug 14.

PMID:
28809079
3.

Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.

Hoffman V, Xue F, Gardstein B, Skerry K, Critchlow CW, Enger C.

Osteoporos Int. 2016 Apr;27(4):1653-1658. doi: 10.1007/s00198-015-3402-9. Epub 2015 Nov 11.

PMID:
26558380
4.

Development and evaluation of an algorithm to identify users of Prolia(®) during the early postmarketing period using health insurance claims data.

Hoffman V, Xue F, Gardstein B, Skerry K, Critchlow CW, Enger C.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):993-8. doi: 10.1002/pds.3680. Epub 2014 Jul 23.

PMID:
25052047
5.

Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research.

Reams BD, O'Malley CD, Critchlow CW, Lauffenburger JC, Brookhart MA.

Pharmacoepidemiol Drug Saf. 2014 Mar;23(3):251-60. doi: 10.1002/pds.3545. Epub 2013 Nov 25.

PMID:
24273152
6.

Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women.

Balasubramanian A, Brookhart MA, Goli V, Critchlow CW.

Int J Gen Med. 2013 Nov 6;6:839-48. doi: 10.2147/IJGM.S36944. eCollection 2013.

7.

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis.

Xue F, Ma H, Stehman-Breen C, Haller C, Katz L, Wagman RB, Critchlow CW; Denosumab Global Safety Assessment Team.

Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1107-14. doi: 10.1002/pds.3477. Epub 2013 Jul 15.

8.

Completeness of prescription information in US commercial claims databases.

Lauffenburger JC, Balasubramanian A, Farley JF, Critchlow CW, O'Malley CD, Roth MT, Pate V, Brookhart MA.

Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):899-906. doi: 10.1002/pds.3458. Epub 2013 May 21.

9.

Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion.

Boudreau DM, Yu O, Spangler L, Do TP, Fujii M, Ott SM, Critchlow CW, Scholes D.

Bone. 2013 Feb;52(2):596-601. doi: 10.1016/j.bone.2012.11.013. Epub 2012 Nov 19.

PMID:
23174214
10.

Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database.

Hernandez RK, Do TP, Critchlow CW, Dent RE, Jick SS.

Acta Orthop. 2012 Dec;83(6):653-60. doi: 10.3109/17453674.2012.747054. Epub 2012 Nov 9.

11.

HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.

Pavlinac PB, Hawes SE, Gottlieb GS, Gaye A, N'Diaye CF, Critchlow CW, Sow PS, Feng Q, Kiviat NB.

Sex Transm Infect. 2012 Feb;88(1):45-50. doi: 10.1136/sextrans-2011-050231.

12.

Relationship between epoetin alfa dose and mortality: findings from a marginal structural model.

Wang O, Kilpatrick RD, Critchlow CW, Ling X, Bradbury BD, Gilbertson DT, Collins AJ, Rothman KJ, Acquavella JF.

Clin J Am Soc Nephrol. 2010 Feb;5(2):182-8. doi: 10.2215/CJN.03040509. Epub 2009 Dec 17.

13.

Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.

Bradbury BD, Brookhart MA, Winkelmayer WC, Critchlow CW, Kilpatrick RD, Joffe MM, Feldman HI, Acquavella JF, Wang O, Rothman KJ.

Am J Kidney Dis. 2009 Sep;54(3):554-60. doi: 10.1053/j.ajkd.2009.05.010. Epub 2009 Jul 9. Review.

PMID:
19592144
14.

Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.

Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):932-40. doi: 10.1002/pds.1799.

PMID:
19572312
15.

Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL.

Bradbury BD, Danese MD, Gleeson M, Critchlow CW.

Clin J Am Soc Nephrol. 2009 Mar;4(3):630-7. doi: 10.2215/CJN.03580708. Epub 2009 Mar 4.

16.

Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.

Hawes SE, Sow PS, Stern JE, Critchlow CW, Gottlieb GS, Kiviat NB.

AIDS. 2008 Nov 30;22(18):2517-25. doi: 10.1097/QAD.0b013e328315cdbc.

17.

Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.

Bradbury BD, Critchlow CW, Weir MR, Stewart R, Krishnan M, Hakim RH.

Nephrol Dial Transplant. 2009 Mar;24(3):919-25. doi: 10.1093/ndt/gfn543. Epub 2008 Oct 7.

PMID:
18840893
18.

The effect of epoetin dose on hematocrit.

Critchlow CW, Bradbury BD, Acquavella JF, Ruixo JJ, Krishnan M, Chow AT, Brenner RM.

Kidney Int. 2008 Sep;74(6):827; author reply 827-8. doi: 10.1038/ki.2008.281. No abstract available.

19.

HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal.

Gottlieb GS, Hawes SE, Wong KG, Raugi DN, Agne HD, Critchlow CW, Kiviat NB, Sow PS.

AIDS Res Hum Retroviruses. 2008 Jun;24(6):857-64. doi: 10.1089/aid.2008.0015.

20.

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.

Kilpatrick RD, Critchlow CW, Fishbane S, Besarab A, Stehman-Breen C, Krishnan M, Bradbury BD.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1077-83. doi: 10.2215/CJN.04601007. Epub 2008 Apr 16.

21.

Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals.

Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM.

J Invest Dermatol. 2008 Jun;128(6):1409-17. doi: 10.1038/sj.jid.5701227. Epub 2008 Jan 10.

22.

Exploring relative mortality and epoetin alfa dose among hemodialysis patients.

Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF.

Am J Kidney Dis. 2008 Jan;51(1):62-70.

PMID:
18155534
23.

HIV prevalence, previous HIV testing, and condom use with clients and regular partners among Senegalese commercial sex workers.

Wang C, Hawes SE, Gaye A, Sow PS, Ndoye I, Manhart LE, Wald A, Critchlow CW, Kiviat NB.

Sex Transm Infect. 2007 Dec;83(7):534-40. Epub 2007 Oct 17.

24.

Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW.

Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99. Epub 2006 Nov 29.

25.

The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.

Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB.

J Infect Dis. 2007 Sep 15;196(6):887-94. Epub 2007 Aug 7.

PMID:
17703420
26.

The association of temporomandibular disorder pain with history of head and neck injury in adolescents.

Fischer DJ, Mueller BA, Critchlow CW, LeResche L.

J Orofac Pain. 2006 Summer;20(3):191-8.

PMID:
16913428
27.

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE, Wood T, Jeronimo C, Rosenbaum E, Stern J, Yu M, Trink B, Kiviat NB, Sidransky D.

J Clin Oncol. 2006 Sep 10;24(26):4262-9. Epub 2006 Aug 14.

PMID:
16908936
28.

Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.

Gottlieb GS, Hawes SE, Agne HD, Stern JE, Critchlow CW, Kiviat NB, Sow PS.

AIDS. 2006 Apr 4;20(6):895-900.

29.

Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.

Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.

J Natl Cancer Inst. 2006 Jan 18;98(2):100-9.

PMID:
16418512
30.

Risk factors for group B streptococcal genitourinary tract colonization in pregnant women.

Stapleton RD, Kahn JM, Evans LE, Critchlow CW, Gardella CM.

Obstet Gynecol. 2005 Dec;106(6):1246-52.

PMID:
16319248
31.

Detecting small for gestational age infants: the development of a population-based reference for Washington state.

Lipsky S, Easterling TR, Holt VL, Critchlow CW.

Am J Perinatol. 2005 Nov;22(8):405-12.

PMID:
16283599
32.

A sister's risk: family history as a predictor of preeclampsia.

Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):965-72.

PMID:
16157095
33.

Police-reported intimate partner violence during pregnancy: who is at risk?

Lipsky S, Holt VL, Easterling TR, Critchlow CW.

Violence Vict. 2005 Feb;20(1):69-86.

PMID:
16047936
34.

Childhood asthma hospitalization risk after cesarean delivery in former term and premature infants.

Debley JS, Smith JM, Redding GJ, Critchlow CW.

Ann Allergy Asthma Immunol. 2005 Feb;94(2):228-33.

PMID:
15765737
35.

Detection of hypermethylated genes in women with and without cervical neoplasia.

Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB.

J Natl Cancer Inst. 2005 Feb 16;97(4):273-82.

PMID:
15713962
36.

Impact of adolescence and gender on asthma hospitalization: a population-based birth cohort study.

Debley JS, Redding GJ, Critchlow CW.

Pediatr Pulmonol. 2004 Dec;38(6):443-50.

PMID:
15690559
37.

Characteristics and presenting complaints of outpatients with undiagnosed HIV infection: potential utility in selecting subjects for HIV testing.

Sow PS, Hawes SE, Critchlow CW, McIntosh MW, Diop A, Diouf MB, Gottlieb GS, Starling AK, Coll-Seck AM, Kiviat NB.

J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1520-8.

PMID:
15602131
38.

No evidence for recombination between HIV type 1 and HIV type 2 within the envelope region in dually seropositive individuals from Senegal.

Curlin ME, Gottlieb GS, Hawes SE, Sow PS, Ndoye I, Critchlow CW, Kiviat NB, Mullins JI.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):958-63.

PMID:
15585083
39.

Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

Zheng NN, Kiviat NB, Sow PS, Hawes SE, Wilson A, Diallo-Agne H, Critchlow CW, Gottlieb GS, Musey L, McElrath MJ.

J Virol. 2004 Dec;78(24):13934-42.

40.

Association between mandibular retrognathia and TMJ disorders in adult females.

Miller JR, Burgess JA, Critchlow CW.

J Public Health Dent. 2004 Summer;64(3):157-63.

PMID:
15341139
41.

Influence of study population on the identification of risk factors for sexually transmitted diseases using a case-control design: the example of gonorrhea.

Manhart LE, Aral SO, Holmes KK, Critchlow CW, Hughes JP, Whittington WL, Foxman B.

Am J Epidemiol. 2004 Aug 15;160(4):393-402.

PMID:
15286025
42.

Police-reported intimate partner violence during pregnancy and the risk of antenatal hospitalization.

Lipsky S, Holt VL, Easterling TR, Critchlow CW.

Matern Child Health J. 2004 Jun;8(2):55-63.

PMID:
15198172
43.

HIV infection and human herpesvirus-8 oral shedding among men who have sex with men.

Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, Hawes SE, Critchlow CW, Morrow RA, Corey L, Kiviat N, Wald A.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):233-8.

PMID:
15076237
44.

Cardiovascular and thromboembolic events following hypertensive pregnancy.

Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, Schwartz SM.

Am J Kidney Dis. 2003 Nov;42(5):982-9.

PMID:
14582042
45.

Impact of police-reported intimate partner violence during pregnancy on birth outcomes.

Lipsky S, Holt VL, Easterling TR, Critchlow CW.

Obstet Gynecol. 2003 Sep;102(3):557-64.

PMID:
12962943
46.

Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa.

Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Coll-Seck AM, Curlin ME, Critchlow CW, Kiviat NB, Mullins JI.

AIDS Res Hum Retroviruses. 2003 Jul;19(7):575-84.

PMID:
12908935
47.

Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.

Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Touré P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat NB.

J Infect Dis. 2003 Aug 15;188(4):555-63. Epub 2003 Jul 23.

PMID:
12898443
48.

Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain.

John MT, Miglioretti DL, LeResche L, Von Korff M, Critchlow CW.

Pain. 2003 Apr;102(3):257-63.

PMID:
12670667
49.

Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men.

Spielberg F, Branson BM, Goldbaum GM, Lockhart D, Kurth A, Celum CL, Rossini A, Critchlow CW, Wood RW.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):318-27.

PMID:
12626893
50.

Mucopurulent cervicitis and Mycoplasma genitalium.

Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, Totten PA.

J Infect Dis. 2003 Feb 15;187(4):650-7. Epub 2003 Jan 29. Erratum in: J Infect Dis. 2004 Aug 15;190(4):866.

PMID:
12599082

Supplemental Content

Loading ...
Support Center